NCT04561102 Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population Status COMPLETED Phase N/A
NCT04561089 Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel Status COMPLETED Phase N/A
NCT04560413 Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients Status COMPLETED Phase N/A
NCT04546581 Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Status COMPLETED Phase PHASE3
NCT04540185 A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 Status UNKNOWN Phase PHASE3
NCT04534608 COVID-19 Child Health Investigation of Latent Disease in Hamburg Status UNKNOWN Phase N/A
NCT04527471 Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 Status COMPLETED Phase PHASE2
NCT04526821 Lactoferrin for Prevention of COVID-19 in Health Care Workers Status TERMINATED Phase PHASE2
NCT04523571 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects Status COMPLETED Phase PHASE1
NCT04519372 SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting Status COMPLETED Phase N/A
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults Status COMPLETED Phase PHASE3
NCT04515147 A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 Status COMPLETED Phase PHASE2
NCT04498325 Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) Status WITHDRAWN Phase PHASE1
NCT04488588 Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt Status COMPLETED Phase N/A
NCT04480957 Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects Status COMPLETED Phase PHASE1/PHASE2